Comparison of a Test for Soluble Fibrin Polymer (TpP^TM) with a Standard Quantitative ELISA for D-dimer in Patients, without Current Thrombosis, who Have Cancer or Renal Disease

• References

• 1 LaCapra S, Arkel YS, Ku DH, Gibson D, Lake C, Lam X. The use of thrombus precursor protein, D-dimer, prothrombin fragment 1.2, and thrombin antithrombin in the exclusion of proximal deep vein thrombosis and pulmonary embolism. Blood Coagul Fibrinolysis 2000; 11: 371-377.
• 2 Bates SM, Grand’Maison A, Johnston M, McGrath J, Ginsberg JS. Use of the thrombus precursor protein (TpP) to exclude deep vein thrombosis [abstract]. Thromb Haemost 1999; 82 (Suppl. 01) 259.
• 3 Janssen MCH, Heebels AE, de Metz M, Verbruggen H, Wollersheim H, Janssen S, Schuurmans MMJ, Nováková IRO. Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis. Thromb Haemost 1997; 77: 262-6.
• 4 Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994; 104: 134-44.
• 5 van der Graaf F, van den Borne H, van der Kolk M, de Wild PJ, Janssen GWT, van Uum SHM. Exclusion of deep venous thrombosis with D-dimer testing: comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost 2000; 83: 191-8.
• 6 Gouin Thibault I, Samama MM. Laboratory diagnosis of the thrombophilic state in cancer patients. Semin Thromb Hemost 1999; 25: 167-72.
• 7 Gaffney PJ, Creighton LJ, Callus MJ, Thorpe R. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II Evolution in a variety of clinical conditions. Br J Haematol 1988; 68: 91-6.
• 8 Ghirardini G, Battioni M, Bertellini C, Colombini R, Colla R, Rossi G. D-dimer after delivery in uncomplicated pregnancies. Clin Exp Obstet Gynecol 1999; 26: 211-2.